drugset / Trial / NCT00566904
New Topical Treatment for Continued Pain After Shingles
Phase 1
Completed
30 enrolled
Biomedical Development Corporation
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · collabThe University of Texas Health Science Center, Houston · collab
RandomizedCrossoverSingle-blindTreatment
Summary
Shingles is an outbreak of rash or blisters on the skin that is caused by the same virus that causes chicken pox. Some people experience continued pain even after the shingles rash and blisters have healed; this pain is known as postherpetic neuralgia. The purpose of this study is to evaluate the effectiveness of a new topical treatment for postherpetic neuralgia in adults.
Timeline
- Start
- 2006-09
- Primary completion
- 2008-08
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | — | Topical |
| Subject | Lidocaine | Other / unclassified | — | Topical |